Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. 詳細を表示
REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...
Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for...
REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.02 | 0.320512820513 | 6.24 | 7.27 | 6.24 | 314689 | 6.7759264 | CS |
4 | 0.45 | 7.74526678141 | 5.81 | 7.27 | 5.81 | 219083 | 6.63706204 | CS |
12 | 0.09 | 1.45867098865 | 6.17 | 7.82 | 5.72 | 235246 | 6.5659134 | CS |
26 | -1.54 | -19.7435897436 | 7.8 | 8.79 | 5.46 | 263608 | 6.91934724 | CS |
52 | -6.23 | -49.8799039231 | 12.49 | 14.92 | 5.46 | 371745 | 8.3858304 | CS |
156 | -20.99 | -77.0275229358 | 27.25 | 29.25 | 4.07 | 393759 | 12.32911359 | CS |
260 | -31.74 | -83.5263157895 | 38 | 69.4779 | 4.07 | 375342 | 20.52735422 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約